Overview

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Status:
RECRUITING
Trial end date:
2030-03-02
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of autologous hematopoietic stem cell transplantation (ASCT) combined with BCMA-CART in the treatment of UHR-MM.
Phase:
PHASE1
Details
Lead Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Collaborator:
Hebei Taihe Chunyu Biotechnology Co., Ltd